Stockwatch: Coronavirus Impacts At Generic Pharmaceuticals – A Mixed Bag
Supply Chains Seem Unaffected, But Volume Challenges Remain
Following Mylan’s first-quarter 2020 earnings announcement, all the biggest generic pharmaceutical companies have now reported. Concerns about supply chain disruptions in March have proven to have been overblown and guidance has largely been reaffirmed. So, are generics immune from coronavirus?
